Benefit-and-cost analysis of medical interventions : the case of cimetidine and peptic ulcer disease /
Main Author: | Fineberg, Harvey V |
---|---|
Corporate Author: | United States Congress. Office of Technology Assessment |
Other Authors: | Pearlman, Laurie A |
Format: | Government Document Book |
Language: | English |
Published: |
Washington, D.C. :
Congress of the United States, Office of Technology Assessment : For sale by the Supt. of Docs., U.S. G.P.O.,
1981
|
Series: | OTA background papers ;
OTA-BP-H-9(11) The Implications of cost-effectiveness analysis of medical technology Background paper. Case studies of medical technologies ; case study #11. |
Subjects: |
Similar Items
-
Benefit-and-cost analysis of medical interventions : the case of cimetidine and peptic ulcer disease /
by: Fineberg, Harvey V, et al.
Published: (1981) -
Benefit-and-cost analysis of medical interventions : the case of cimetidine and peptic ulcer disease /
by: Fineberg, Harvey V
Published: (1981) -
Cost-benefit and cost-effectiveness analysis in policymaking : cimetidine as a model : proceedings of an international symposium, November 22-24, 1981, Tarpon Springs, Florida /
Published: (1982) -
Cimetidine : proceedings of an International Symposium on Histamine H2-Receptor Antagonists, 10th-11th November, 1977, Gottingen, Federal Republic of Germany /
Published: (1978) -
Further experience with H2-receptor antagonists in peptic ulcer disease and progress in histamine research : European symposium, Capri, October 18-20, 1979 /
Published: (1980)